$188 Million is the total value of Martin Capital Partners, LLC's 69 reported holdings in Q1 2021. The portfolio turnover from Q4 2020 to Q1 2021 was 100.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
AIT | Exit | Applied Industrial Technologies | $0 | – | -2,725 | -100.0% | -0.12% | – |
SPY | Exit | Spdr S&P 500 ETF Trtr unit | $0 | – | -1,733 | -100.0% | -0.38% | – |
GSK | Exit | GlaxoSmithKline Plcsponsored adr | $0 | – | -67,659 | -100.0% | -1.46% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-04-14
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
PFIZER INC | 25 | Q4 2023 | 5.1% |
Johnson & Johnson Co | 25 | Q4 2023 | 4.7% |
JPMORGAN CHASE & CO | 25 | Q4 2023 | 3.8% |
AMGEN INC | 25 | Q4 2023 | 3.9% |
Cisco Systems, Inc. | 25 | Q4 2023 | 4.8% |
Chevron Corporation | 25 | Q4 2023 | 3.6% |
Verizon Communications Inc. | 25 | Q4 2023 | 3.3% |
Texas Instruments Incorporated | 25 | Q4 2023 | 3.8% |
Coca-Cola Company | 25 | Q4 2023 | 3.1% |
Microsoft Corporation | 25 | Q4 2023 | 3.8% |
View Martin Capital Partners, LLC's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-04-05 |
13F-HR | 2024-01-08 |
13F-HR | 2023-10-13 |
13F-HR | 2023-07-17 |
13F-HR | 2023-04-05 |
13F-HR | 2023-01-05 |
13F-HR | 2022-10-06 |
13F-HR | 2022-07-08 |
13F-HR | 2022-04-06 |
13F-HR | 2022-01-07 |
View Martin Capital Partners, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.